Evora Biosciences
Entity

  • Evora Biosciences

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,392

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 2-10

    Estimated: 7

  • SIREN

    882655699

  • Engaged corporates

    4
    3 1

  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    First-in-class immunomodulatory peptides.

    Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.

    immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation

  • Original language

    First-in-class immunomodulatory peptides.

    Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.

Corporate interactions BETA
Corporate TypeTweets Articles
BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research 		Other

14 Mar 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care 		Other

30 Apr 2023


Erganeo
Erganeo
Research, National and local authorities, Research Services
Erganeo
Research, National and local authorities, Research Services 		Other

22 Jun 2023


CNRS Innovation
CNRS Innovation
Research, Research Services
CNRS Innovation
Research, Research Services 		Other

29 Jun 2023


Similar entities
Last news
Show all articles
Social network dynamics